Please login to the form below

Not currently logged in
Email:
Password:

Kymab appoints its first chief medical officer

Dr Sonia Quaratino joins the firm from Novartis

Sonia QuaratinoKymab has appointed Dr Sonia Quaratino as its chief medical officer - a newly created role that will see her manage clinical development of the group’s expanding therapeutic antibody portfolio.

She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.

Dr Quaratino said: “Kymab’s emerging human antibody pipeline provides great potential to improve patient treatment options in our four main therapeutics areas of focus."

She previous served Novartis as its global clinical programme leader, transitional clinical oncology, with responsibility for the clinical development of proprietary therapeutic antibody programmes in immuno-oncology.

Prior to her time at Novartis, Quaratino worked for Merck Serono, where she was responsible for the clinical development of various immunomodulators.

Dr David Chiswell, CEO of Kymab, said: “I am delighted to welcome Sonia to Kymab. With her track demonstrated track record in clinical development and medical affairs, Sonia is a superb addition to Kymab’s management team as we prepare for our first clinical trials.

“Sonia’s deep understanding of the global environment in clinical research compliment those of Dr Arndt Schottelius, our new executive VP of R&D. These two key appointments add high calibre of depth and provide further validation to our burgeoning and advancing R&D pipeline.”

10th May 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics